Dr Matthew Fittall

Dr Matthew Fittall is a Consultant Clinical Oncologist who specialises in the management and treatment of urological cancers. He offers compassionate, patient-centred care to individuals facing diagnoses of prostate, bladder, and penile malignancies. By integrating evidence-based oncological techniques with individualised therapeutic strategies, Dr Fittall aims to deliver reassuring guidance and optimal clinical outcomes for every patient under his care.

Dr Fittall completed his pre-clinical medical studies and natural sciences degree at the University of Cambridge before earning his medical degree (BMBCh) from the University of Oxford in 2008. He later completed a Master of Science in Oncology and was awarded a PhD focusing on cancer genomic evolution. He qualified as a Member of the Royal College of Physicians (MRCP) in 2011 and achieved Fellowship of the Royal College of Radiologists (FRCR) in 2016, receiving the Royal College of Radiologists Gold Medal. His professional memberships include the Royal College of Physicians and the Royal College of Radiologists.

In his clinical practice, Dr Fittall specialises in advanced radiotherapy techniques and systemic chemotherapy regimens for urological conditions. His key areas of interest include prostate cancer, bladder cancer, and penile cancer. Alongside his direct clinical responsibilities, he contributes to academic research investigating radiation resistance and cancer genomics, ensuring that his patients benefit from modern advancements in oncology.

Dr Fittall is committed to maintaining open, clear, and reassuring communication with his patients and their families throughout the treatment process. He prioritises helping patients thoroughly understand their condition and management options, empowering them to make confident and well-informed decisions regarding their health.